The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

LOS ANGELES, Dec. 13 (Xinhua) -- An injectable HIV drug with novel mechanism was named on Thursday by the influential U.S. journal "Science" as Breakthrough of the Year. The drug, named lenacapavir, ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...

Science, a global scientific journal, has selected lenacapavir (lenacapavir), a groundbreaking HIV infection treatment, and related studies for the '2024 Innovation of the Year'. Renacapavir, an ...

The pupils of Fangcaodi International School, a state-run primary school in Beijing with an emphasis on science education, have closely followed China’s recent lunar endeavours. In June ...

Plenty of the book will appeal to both music fans and science buffs, but Levitin also recognizes that some degree of mystery will always surround music’s ability to move us. He argues ...

Welcome to ScienceDaily, owned by Chris Hogan, a passionate advocate for science, cutting-edge technology, and the dissemination of knowledge. Born in Canada and raised in North Potomac ...